Search Results

. Cullen M Steven N Billingham L . Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas . N Engl J Med 2005 ; 353 : 988 – 998 . 6. Lyman GH Kuderer NM Djulbegovic B . Prophylactic granulocyte colony-stimulating factor

agents and diagnostic adjuncts . Clin Infect Dis 2007 ; 44 : 402 – 409 . 3. Segal BH Freifeld AG . Antibacterial prophylaxis in patients with neutropenia . J Natl Compr Canc Netw 2007 ; 5 : 235 – 242 . 4. Kuhlman JE Fishman EK

. 4 Bodey GP Rodriguez V Chang HY . Fever and infection in leukemic patients . Cancer 1978 ; 41 : 1610 - 1622 . 5 Cruciani M Rampazzo R Malena M . Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: A

the incidence of MM has uniformly increased over the last several decades, 8 the question of optimal VTE prophylaxis is of even greater importance in this disease entity for successful long-term outcomes for all patients. Currently, official

safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized double blind study . J Infect Dis 1995 ; 171 : 1545 – 1552 . 3. Cornely OA Ullmann AJ Karthaus M . Evidence-based assessment of

individual cancer patients or in specific settings therefore becomes especially important to applying targeted thromboprophylaxis. Knowledge gained within the past decade has improved understanding of risk assessment and prophylaxis of cancer-associated VTE

for patients with cancer. CINV prophylaxis remains the fundamental strategy, because once patients experience CINV they are 4 times more likely to experience nausea and vomiting in subsequent cycles of chemotherapy. 2 Several organizations have

report . Available at : http://www.ahrq.gov/qual/nqfpract.pdf . Accessed July 15, 2008 . 4. Tapson VF Decousus H Pini M . Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients . Chest 2007 ; 132 : 936 – 945

. Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: Cytostatics are a more important risk factor than antibacterial prophylaxis . Clin Infect Dis 1995 ; 20 : 469 – 470 . 10 Bow EJ Loewen R Cheang MS . Cytotoxic

outpatient chemotherapy . J Thromb Haemost 2007 ; 5 : 632 – 634 . 5. Shen VS Pollak EW . Fatal pulmonary embolism in cancer patients: is heparin prophylaxis justified? South Med J 1980 ; 73 : 841 - 843 . 6. Lee AY Levine MN